BTW, the Yahoo board for XCHO has been destroyed, go to the I-Hub one for better info and more civil environment.

Cheers


This was of course due to the RedChip Buy rating yesterday with 350% gain short term target.  Its up 35% since the report came out.

The Chart http://stockcharts.com/charts/gallery.html?xcho also shows a 1.25 Point an Figure Target

You can get the RedChip 25 page Report free here: http://www.redchip.com/about/aboutmain.asp?rid=262

It was written well know biotech analysts David Webber

David Webber
Research Analyst
David Webber has been covering the biotechnology industry since 1989. Previously, he was a senior biotechnology analyst with Alex. Brown & Sons, Warburg Dillon Read, and First Albany. He was named to the Wall Street Journal “Best on the Street” biotechnology team in 2005. Mr. Webber earned an M.A. in English at Columbia University.

The short term target 12-18 months is $.90 and based on just 10 P/E the 2015 target is $2.95.

In addition Monday the company announced a 2500 ad TV campaign for the new Cobroxin OTC pain med. The company is already profitable.